Most Mycoplasmas are difficult to grow in axenic culture, requering complex media that includes animal serum. This makes the production process of vaccines based on mycoplasma very irreproducible and prone to contamination by animal viruses.We envision to optimize a chassis free of virulence determinants from M.pneumoniae and will be optimized for fast growth in a serum-free medium.
